154 related articles for article (PubMed ID: 33521930)
21. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
[TBL] [Abstract][Full Text] [Related]
22. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.
Qi L; Lu Z; Sun YH; Song HT; Xu WK
Int J Mol Med; 2016 Dec; 38(6):1734-1742. PubMed ID: 27748839
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract][Full Text] [Related]
24. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.
Yu G; Lee YC; Cheng CJ; Wu CF; Song JH; Gallick GE; Yu-Lee LY; Kuang J; Lin SH
Mol Cancer Res; 2015 Feb; 13(2):348-57. PubMed ID: 25189355
[TBL] [Abstract][Full Text] [Related]
25. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
[TBL] [Abstract][Full Text] [Related]
27. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.
Cultrara CN; Kozuch SD; Ramasundaram P; Heller CJ; Shah S; Beck AE; Sabatino D; Zilberberg J
BMC Cancer; 2018 Dec; 18(1):1263. PubMed ID: 30563499
[TBL] [Abstract][Full Text] [Related]
28. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription.
Wu K; Fan J; Zhang L; Ning Z; Zeng J; Zhou J; Li L; Chen Y; Zhang T; Wang X; Hsieh JT; He D
Cell Signal; 2012 Dec; 24(12):2273-82. PubMed ID: 22906492
[TBL] [Abstract][Full Text] [Related]
29. Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.
Stankiewicz E; Mao X; Mangham DC; Xu L; Yeste-Velasco M; Fisher G; North B; Chaplin T; Young B; Wang Y; Kaur Bansal J; Kudahetti S; Spencer L; Foster CS; Møller H; Scardino P; Oliver RT; Shamash J; Cuzick J; Cooper CS; Berney DM; Lu YJ
Sci Rep; 2017 Jul; 7(1):5124. PubMed ID: 28698647
[TBL] [Abstract][Full Text] [Related]
30. Cells susceptible to epithelial-mesenchymal transition are enriched in stem-like side population cells from prostate cancer.
Luo Y; Cui X; Zhao J; Han Y; Li M; Lin Y; Jiang Y; Lan L
Oncol Rep; 2014 Feb; 31(2):874-84. PubMed ID: 24316717
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA
Misawa A; Kondo Y; Takei H; Takizawa T
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514011
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
33. Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer.
Shin SH; Kim I; Lee JE; Lee M; Park JW
Oncogene; 2020 Sep; 39(36):5839-5854. PubMed ID: 32796959
[TBL] [Abstract][Full Text] [Related]
34. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
35. The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
Huang Q; Miller MR; Schappet J; Henry MD
Cancer Biol Ther; 2015; 16(1):125-36. PubMed ID: 25455932
[TBL] [Abstract][Full Text] [Related]
36. DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.
Wang B; Huang J; Zhou J; Hui K; Xu S; Fan J; Li L; Wang X; Hsieh JT; He D; Wu K
Cell Signal; 2016 Nov; 28(11):1623-30. PubMed ID: 27476001
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer.
Stewart PA; Khamis ZI; Zhau HE; Duan P; Li Q; Chung LWK; Sang QA
Oncotarget; 2017 Jun; 8(24):39209-39217. PubMed ID: 28424404
[TBL] [Abstract][Full Text] [Related]
38. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
[TBL] [Abstract][Full Text] [Related]
39. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.
Liu CH; Tang WC; Sia P; Huang CC; Yang PM; Wu MH; Lai IL; Lee KH
Int J Med Sci; 2015; 12(1):63-71. PubMed ID: 25552920
[TBL] [Abstract][Full Text] [Related]
40. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
Chen QG; Zhou W; Han T; Du SQ; Li ZH; Zhang Z; Shan GY; Kong CZ
J Cancer Res Clin Oncol; 2016 Jan; 142(1):213-24. PubMed ID: 26227059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
